Sort
16,300 grants matching “fatty liver disease”
METABOLIC FUNCTIONS OF ADIPOCYTE PEROXISOMES
$362,188Xiong Su · Washington University · R01 · FY2017 · DK
METABOLIC FUNCTIONS OF ADIPOCYTE PEROXISOMES
$362,188Xiong Su · Washington University · R01 · FY2016 · DK
METABOLIC FUNCTIONS OF ADIPOCYTE PEROXISOMES
$362,188Xiong Su · Washington University · R01 · FY2014 · DK
METABOLIC FUNCTIONS OF ADIPOCYTE PEROXISOMES
$362,188Xiong Su · Washington University · R01 · FY2015 · DK
Design and Use of Methods for Peptide Secretion Studies
$362,182Robert T Kennedy · University Of Michigan At Ann Arbor · R37 · FY2015 · DK
Genetics of Type 2 Diabetes
$362,159Steven C Elbein · Univ Of Arkansas For Med Scis · R01 · FY2007 · DK
Fatty liver in HIV infected individuals
$362,098Samer Gawrieh · Indiana University Indianapolis · R01 · FY2018 · DK
1/2 Howard-Georgetown Collaborative Partnership In Cancer Research
$362,078Carla D Williams · Howard University · P20 · FY2021 · CA
The impact of the unfolded protein responses on steatosis
$362,076Kirsten C Sadler Edepli · Icahn School Of Medicine At Mount Sinai · R01 · FY2015 · AA
Dissecting the Role of Arachidonic Acid Metabolic Pathways Involved in Resolution Versus Progression of PM-Induced Cardiometabolic Toxicity
$362,050Jesus Antonio Araujo · University Of California Los Angeles · R01 · FY2023 · ES
Molecular Dissection of E. Histolytica Pathogenesis
$361,970William F. Stenson · Washington University · R01 · FY2009 · AI
Molecular Dissection of E. Histolytica Pathogenesis
$361,970Samuel L. Stanley · Washington University · R01 · FY2008 · AI
Fatty liver in HIV infected individuals
$361,913Samer Gawrieh · Indiana University Indianapolis · R01 · FY2019 · DK
Liver Disease in Obesity
$361,900Duke University · R01 · FY2004 · DK
Liver Disease in Obesity
$361,900Duke University · R01 · FY2005 · DK
Does the inhibition of key xenobiotic-metabolizing CYPs cause obesity?
$361,775William S Baldwin · Clemson University · R15 · FY2016 · ES
Fatty liver in HIV infected individuals
$361,721Samer Gawrieh · Indiana University Indianapolis · R01 · FY2020 · DK
Peripheral CB1 Receptor Antagonist for Therapeutic Use in Metabolic Syndrome
$361,596Xin Xu · National Center For Advancing Translational Sciences · ZIA · FY2016 · TR
Fatty liver in HIV infected individuals
$361,523Samer Gawrieh · Indiana University Indianapolis · R01 · FY2021 · DK
Core B: Mouse Models of Aging and Cancer
$361,442Alessandra Sacco · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2025 · AG
Project 2: Cytoplasmic chromatin fragments (CCF) as a driver of liver cancer and target for intervention during aging
$361,442Peter D. Adams · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2025 · AG
Project 4: Interrogating and harnessing age-related IFN signaling and innate immunity in HCC prevention and therapy
$361,440Gen-Sheng Feng · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2025 · AG
Fine-tuning lipid metabolism by LSD1
$361,413Fajun James Yang · Albert Einstein College Of Medicine · R01 · FY2011 · DK
Development of A Dual Chemokine CCL2/CCL5 Neutralizing Single-domainAntibody for Treating Non-alcoholic Steatohepatitis
$361,400Xiang Gao · Oncotrap, Inc. · R43 · FY2023 · DK
Functional studies of KLF-14, a putative master regulator of metabolism
$361,313Kiran Musunuru · University Of Pennsylvania · R01 · FY2016 · DK